Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Gleeson

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Cancer|August 20, 2009
Why are pretreatment prostate-specific antigen levels and biochemical recurrence poor predictors of prostate cancer survival?James W Denham, Allison Steigler, Chantelle Wilcox, et al.
The British Journal of Psychiatry : the Journal of Mental Science|November 29, 2002
Maternal recall bias, obstetric history and schizophreniaA M McIntosh, S Holmes, S Gleeson, et al.
International Journal of Radiation Oncology, Biology, Physics|July 7, 2009
Measuring time to biochemical failure in the TROG 96.01 trial: when should the clock start ticking?James W Denham, Allison Steigler, Mahesh Kumar, et al.
The Lancet. Oncology|October 22, 2008
Time to biochemical failure and prostate-specific antigen doubling time as surrogates for prostate cancer-specific mortality: evidence from the TROG 96.01 randomised controlled trialJames W Denham, Allison Steigler, Chantelle Wilcox, et al.
International Journal of Radiation Oncology, Biology, Physics|January 30, 2009
Recognizing false biochemical failure calls after radiation with or without neo-adjuvant androgen deprivation for prostate cancerJames W Denham, Mahesh Kumar, Paul S Gleeson, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Cancer|August 20, 2009
Why are pretreatment prostate-specific antigen levels and biochemical recurrence poor predictors of prostate cancer survival?James W Denham, Allison Steigler, Chantelle Wilcox, et al.
The British Journal of Psychiatry : the Journal of Mental Science|November 29, 2002
Maternal recall bias, obstetric history and schizophreniaA M McIntosh, S Holmes, S Gleeson, et al.
International Journal of Radiation Oncology, Biology, Physics|July 7, 2009
Measuring time to biochemical failure in the TROG 96.01 trial: when should the clock start ticking?James W Denham, Allison Steigler, Mahesh Kumar, et al.
The Lancet. Oncology|October 22, 2008
Time to biochemical failure and prostate-specific antigen doubling time as surrogates for prostate cancer-specific mortality: evidence from the TROG 96.01 randomised controlled trialJames W Denham, Allison Steigler, Chantelle Wilcox, et al.
International Journal of Radiation Oncology, Biology, Physics|January 30, 2009
Recognizing false biochemical failure calls after radiation with or without neo-adjuvant androgen deprivation for prostate cancerJames W Denham, Mahesh Kumar, Paul S Gleeson, et al.
Pageof 4